Neurogenic Bowel
27
5
7
13
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
3.7%
1 terminated out of 27 trials
92.9%
+6.4% vs benchmark
11%
3 trials in Phase 3/4
31%
4 of 13 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 13 completed trials
Clinical Trials (27)
Bowel Continence Across the Lifespan in People With Spina Bifida
Abdominal Functional Electrical Stimulation to Improve Bowel Function in Spinal Cord Injury
Electrical Stimulation of Abdominal Muscles for Bowel Management in People With Spinal Cord Injury
Pharmacokinetics of Neostigmine and Glycopyrrolate
Transdermal Administration by a Novel Wireless Iontophoresis Device
Improving Pelvic Rehabilitation Using Epidural Stimulation After Spinal Cord Injury
Transcutaneous Spinal Cord Stimulation for Bowel Management in Individuals with Motor Complete Spinal Cord Injury
Motor & Autonomic Concomitant Health Improvements With Neuromodulation & Exercise Training: An SCI RCT
Below the Belt: Non-invasive Neuromodulation to Treat Bladder, Bowel, and Sexual Dysfunction Following Spinal Cord Injury
Neostigmine and Glycopyrrolate by Iontophoresis
Use of Point-of-care Neuro-sacral Electrophysiology Following Spinal Cord Injury
A Clinical Investigation Evaluating Peristeen® Performance
Comparison of Transcutaneous Electrical Nerve Stimulation and Manual Therapy in Children With Cerebral Palsy
Prebiotics for Spinal Cord Injury Patients With Bowel and Bladder Dysfunction
Improving Bowel Function and Quality of Life After Spinal Cord Injury
The Role of Active Administration of Peristeen Bowel Evacuation for the Management of Urinary Tract Infection
Evaluation of a Novel Electronic Transanal Irrigation System - Navina™ Smart
Sacral Neuromodulation in Neurogenic Patients
Exoskeleton Neurogenic Bowel Dysfunction Study
Use of a Prokinetic Agent as an Adjunct to Thrice Weekly Bowel Care After SCI